Boston Scientific (BSX): CEO sold ~$13.6M
Michael F Mahoney, CEO at Boston Scientific, sold ~$13.6M of Boston Scientific shares.
- ~$13.6M
- Approx. value · 160K sh @ $84.74
- 1.52M
- Holds after · shares reported
- Traded
- Nov 5, 2024
- Filed
- Nov 7, 2024
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Oct 1, 2024InsiderOfficer sold ~$586K of BSX shares in the open market
- Oct 7, 2024Insider · 2 peopleInsiders: 3 sales (~$25.0M)
- Nov 1, 2024InsiderOfficer sold ~$589K of BSX shares in the open market
- Nov 5, 2024 · this disclosureInsiderCEO sold ~$13.6M of BSX shares in the open market
What came next
- Nov 5, 2024InsiderCEO sold ~$221K of BSX shares in the open market
- Nov 8, 2024InsiderOfficer sold ~$2.68M of BSX shares in the open market
- Nov 21, 2024InsiderDirector sold ~$447K of BSX shares in the open market
- Nov 25, 2024InsiderOfficer sold ~$1.25M of BSX shares in the open market
- Nov 27, 2024InsiderOfficer sold ~$121K of BSX shares in the open market
- Dec 2, 2024InsiderOfficer sold ~$634K of BSX shares in the open market
- Dec 3, 2024InsiderOfficer purchased ~$4.5K of BSX shares in the open market
- Dec 10, 2024InsiderOfficer sold ~$1.8K of BSX shares in the open market
- Dec 20, 2024FDARecall: AXIOS Stent and Delivery System 10mmx10mm UPN: M00553740
- Dec 20, 2024FDARecall: HOT AXIOS Stent and Electrocautery- Enhanced Delivery System 10mmx10mm UPN: M00553540
- Dec 20, 2024FDARecall: HOT AXIOS Stent and Electrocautery- Enhanced Delivery System 20mmx10mm UPN: M00553560
- Dec 20, 2024FDARecall: HOT AXIOS Stent and Electrocautery- Enhanced Delivery System 15mmx10mm UPN: M00553550
- Dec 20, 2024FDARecall: AXIOS Stent and Electrocautery- Enhanced Delivery System 15mmx10mm UPN: M00553650
- Dec 20, 2024FDARecall: AXIOS Stent and Electrocautery- Enhanced Delivery System 15mmx15mm UPN: M00553670
- Dec 20, 2024FDARecall: AXIOS Stent and Electrocautery- Enhanced Delivery System 6mmx8mm UPN: M00553680
- Dec 20, 2024FDARecall: AXIOS Stent and Electrocautery- Enhanced Delivery System 10mmx10mm UPN: M00553640
- Dec 20, 2024FDARecall: AXIOS Stent and Electrocautery- Enhanced Delivery System 8mmx8mm UPN: M00553690
- Dec 20, 2024FDARecall: HOT AXIOS Stent and Electrocautery- Enhanced Delivery System 8mmx8mm UPN: M00553530
- Dec 20, 2024FDARecall: HOT AXIOS Stent and Electrocautery- Enhanced Delivery System 15mmx15mm UPN: M00553570
- Dec 20, 2024FDARecall: HOT AXIOS Stent and Electrocautery- Enhanced Delivery System 6mmx8mm UPN: M00553520
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Boston Scientific
For Boston Scientific, OQRO holds 1 insider filing (SEC Form 4 or Form 144), 7 Congress trade reports, 2 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BSX page.
Other recent filings by Michael F Mahoney, Chairman, President & CEO
- SEC Form 4 at Boston Scientific (BSX)Aug 5, 2026
- SEC Form 4 at Boston Scientific (BSX)Feb 3, 2026
- SEC Form 4 at Boston Scientific (BSX)Feb 3, 2026
- SEC Form 4 at Boston Scientific (BSX)Jun 3, 2025
- SEC Form 4 at Boston Scientific (BSX)Jun 3, 2025
The full history of Michael F Mahoney, Chairman, President & CEO is on the profile page.
How this filing works
Explore the data
Common questions
Which Boston Scientific (BSX) insider traded, and how much?
Michael F Mahoney, CEO at Boston Scientific, sold ~$13.6M of Boston Scientific shares. 160K shares at $84.74.
When did it happen, and when was it made public?
Traded: Nov 5, 2024. Filed: Nov 7, 2024. That is 2 days between the two dates.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Boston Scientific recently?
For Boston Scientific, OQRO holds 1 insider filing (SEC Form 4 or Form 144), 7 Congress trade reports, 2 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days. They are listed on the BSX page.
Does this mean BSX stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Boston Scientific
- SEC Form 13F-HRNov 16, 2026
- USAspending.gov award recordOct 1, 2026
- USAspending.gov award recordOct 1, 2026
- USAspending.gov award recordOct 1, 2026
- USAspending.gov award recordOct 1, 2026
- USAspending.gov award recordOct 1, 2026
Everything OQRO holds on this company is on its BSX page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
